Incyte partners with the University of Pennsylvania

Incyte Corp, a pharmaceutical research company focused on developing cancer therapies, announced this morning that it’s partnering with the Abramson Cancer Center at the University of Pennsylvania, a hub for cancer research.

The goal of the collaboration is to share the knowledge and expertise of top drug discovery and development scientists.

In the long-term, the aim is to better understand cancer biology and foster innovation in the practice of immunotherapy, and improve patient outcomes more quickly.

- Advertisement -

Incyte’s research and development team will work jointly with scientists from Abramson to come up with a collaborative model.

– Digital Partners -